39,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
20 °P sammeln
  • Broschiertes Buch

Hepatitis C affects around 32,000 people in Switzerland, but a third of them are unaware of their infection. This "silent epidemic", as the WHO calls it, often goes unnoticed for years and has life-threatening long-term consequences such as liver cancer. This study is the first to take a comprehensive look at the perception of hepatitis C in Switzerland between 1989, when the virus was discovered, and 2002, the year after the national prevention campaign was launched.Using discourse analysis of newspaper articles, archive sources and medical history documents, the work shows how medical…mehr

Produktbeschreibung
Hepatitis C affects around 32,000 people in Switzerland, but a third of them are unaware of their infection. This "silent epidemic", as the WHO calls it, often goes unnoticed for years and has life-threatening long-term consequences such as liver cancer. This study is the first to take a comprehensive look at the perception of hepatitis C in Switzerland between 1989, when the virus was discovered, and 2002, the year after the national prevention campaign was launched.Using discourse analysis of newspaper articles, archive sources and medical history documents, the work shows how medical knowledge, the blood donation scandal and intravenous drug use shaped public discourse. Stylistic devices such as war and shadow metaphors illustrate the dynamic between perception and stigmatization. The role of HIV as the dominant epidemic narrative and the resulting neglect of hepatitis C are critically examined.This book closes a gap in the history of the Swiss epidemic and makes an important contribution to historical and health policy research.
Autorenporträt
Marlon Gattiker, born in Basel in 1993, studied history and social anthropology in Bern and Rome. With a deep interest in historical issues, he is dedicated to researching health discourses. This work is his contribution to the historiographical examination of hepatitis C in Switzerland.